Effects of Maribavir and Selected Indolocarbazoles on Epstein-Barr Virus Protein Kinase BGLF4 and on Viral Lytic Replication

AUTOR(ES)

Gershburg, Edward

FONTE

American Society for Microbiology

RESUMO

The human cytomegalovirus (HCMV) homolog of the Epstein-Barr virus (EBV) protein kinase (PK), UL97, is inhibited by maribavir (1263W94) and selected indolocarbazoles. Here we show that only one of these indolocarbazoles (K252a), but not maribavir, inhibits autophosphorylation of the EBV PK, BGLF4. However, maribavir and another indolocarbazole, NGIC-I, do inhibit EBV DNA synthesis, suggesting that although these last compounds inhibit both HCMV and EBV, they seem to operate through differ-ent pathways.

Documentos Relacionados

• The Epstein-Barr Virus Protein Kinase BGLF4 and the Exonuclease BGLF5 Have Opposite Effects on the Regulation of Viral Protein Production▿
• A Protein Kinase Activity Associated with Epstein-Barr Virus BGLF4 Phosphorylates the Viral Early Antigen EA-D In Vitro
• Protein Kinase C-Independent Activation of the Epstein-Barr Virus Lytic Cycle
• Epstein-Barr Virus Small RNA (EBER) Genes: Differential Regulation during Lytic Viral Replication
• Lytic Viral Replication as a Contributor to the Detection of Epstein-Barr Virus in Breast Cancer